"Fees, Pharmaceutical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Amounts charged to the patient or third-party payer for medication. It includes the pharmacist's professional fee and cost of ingredients, containers, etc.
| Descriptor ID |
D005252
|
| MeSH Number(s) |
N03.219.442.551
|
| Concept/Terms |
Fees, Pharmaceutical- Fees, Pharmaceutical
- Fees, Pharmaceutic
- Fee, Pharmaceutic
- Pharmaceutic Fee
- Pharmaceutic Fees
- Pharmacy Fee
- Pharmaceutical Fees
- Fee, Pharmaceutical
- Pharmaceutical Fee
- Fee, Pharmacy
- Fees, Pharmacy
- Pharmacy Fees
|
Below are MeSH descriptors whose meaning is more general than "Fees, Pharmaceutical".
Below are MeSH descriptors whose meaning is more specific than "Fees, Pharmaceutical".
This graph shows the total number of publications written about "Fees, Pharmaceutical" by people in this website by year, and whether "Fees, Pharmaceutical" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 2 | 3 |
| 2018 | 2 | 6 | 8 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Fees, Pharmaceutical" by people in Profiles.
-
Racial disparities in medication use: imperatives for managed care pharmacy. J Manag Care Spec Pharm. 2020 Nov; 26(11):1468-1474.
-
Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia. Vaccine. 2019 03 07; 37(11):1398-1406.
-
Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. BioDrugs. 2018 Dec; 32(6):585-606.
-
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2018 07 24; 320(4):379-396.
-
The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications. JAMA Dermatol. 2018 04 01; 154(4):456-459.
-
Cost-related Nonadherence to Medication Treatment Plans: Native Hawaiian and Pacific Islander National Health Interview Survey, 2014. Med Care. 2018 04; 56(4):341-349.
-
Sticker shock. Science. 2018 03 23; 359(6382):1348-1349.
-
Legal Challenges to State Drug Pricing Laws. JAMA. 2018 03 06; 319(9):865-866.
-
The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer. Clin Breast Cancer. 2018 04; 18(2):95-113.
-
The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans. J Med Econ. 2018 May; 21(5):537-541.